These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 30132864)
1. HPV16 E7-induced upregulation of KDM2A promotes cervical cancer progression by regulating miR-132-radixin pathway. Ou R; Zhu L; Zhao L; Li W; Tao F; Lu Y; He Q; Li J; Ren Y; Xu Y J Cell Physiol; 2019 Mar; 234(3):2659-2671. PubMed ID: 30132864 [TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus type 16 E7 oncoprotein-induced upregulation of lysine-specific demethylase 5A promotes cervical cancer progression by regulating the microRNA-424-5p/suppressor of zeste 12 pathway. Liu J; Zhao H; Zhang Q; Shi Z; Zhang Y; Zhao L; Ren Y; Ou R; Xu Y Exp Cell Res; 2020 Nov; 396(1):112277. PubMed ID: 32918895 [TBL] [Abstract][Full Text] [Related]
3. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition. Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer. Liu F; Zhang S; Zhao Z; Mao X; Huang J; Wu Z; Zheng L; Wang Q Oncotarget; 2016 Apr; 7(15):19666-79. PubMed ID: 26910911 [TBL] [Abstract][Full Text] [Related]
5. KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling. Wagner KW; Alam H; Dhar SS; Giri U; Li N; Wei Y; Giri D; Cascone T; Kim JH; Ye Y; Multani AS; Chan CH; Erez B; Saigal B; Chung J; Lin HK; Wu X; Hung MC; Heymach JV; Lee MG J Clin Invest; 2013 Dec; 123(12):5231-46. PubMed ID: 24200691 [TBL] [Abstract][Full Text] [Related]
6. HPV16 E6 and E7 upregulate the histone lysine demethylase KDM2B through the c-MYC/miR-146a-5p axys. Peta E; Sinigaglia A; Masi G; Di Camillo B; Grassi A; Trevisan M; Messa L; Loregian A; Manfrin E; Brunelli M; Martignoni G; Palù G; Barzon L Oncogene; 2018 Mar; 37(12):1654-1668. PubMed ID: 29335520 [TBL] [Abstract][Full Text] [Related]
7. RUNX3-mediated up-regulation of miR-29b suppresses the proliferation and migration of gastric cancer cells by targeting KDM2A. Kong Y; Zou S; Yang F; Xu X; Bu W; Jia J; Liu Z Cancer Lett; 2016 Oct; 381(1):138-48. PubMed ID: 27497248 [TBL] [Abstract][Full Text] [Related]
8. Lysine demethylase 2A promotes stemness and angiogenesis of breast cancer by upregulating Jagged1. Chen JY; Li CF; Chu PY; Lai YS; Chen CH; Jiang SS; Hou MF; Hung WC Oncotarget; 2016 May; 7(19):27689-710. PubMed ID: 27029061 [TBL] [Abstract][Full Text] [Related]
9. Transcriptional repression of histone deacetylase 3 by the histone demethylase KDM2A is coupled to tumorigenicity of lung cancer cells. Dhar SS; Alam H; Li N; Wagner KW; Chung J; Ahn YW; Lee MG J Biol Chem; 2014 Mar; 289(11):7483-96. PubMed ID: 24482232 [TBL] [Abstract][Full Text] [Related]
10. CUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesis. Xu J; Fang Y; Wang X; Wang F; Tian Q; Li Y; Xie X; Cheng X; Lu W Oncotarget; 2016 May; 7(21):31520-33. PubMed ID: 27153550 [TBL] [Abstract][Full Text] [Related]
11. Up-regulation of miR-663a inhibits the cancer stem cell-like properties of glioma via repressing the KDM2A-mediated TGF-β/SMAD signaling pathway. Wang L; Lang B; Zhou Y; Ma J; Hu K Cell Cycle; 2021 Oct; 20(19):1935-1952. PubMed ID: 34424812 [TBL] [Abstract][Full Text] [Related]
12. Mammalian lysine histone demethylase KDM2A regulates E2F1-mediated gene transcription in breast cancer cells. Rizwani W; Schaal C; Kunigal S; Coppola D; Chellappan S PLoS One; 2014; 9(7):e100888. PubMed ID: 25029110 [TBL] [Abstract][Full Text] [Related]
13. Elevation of miR-27b by HPV16 E7 inhibits PPARγ expression and promotes proliferation and invasion in cervical carcinoma cells. Zhang S; Liu F; Mao X; Huang J; Yang J; Yin X; Wu L; Zheng L; Wang Q Int J Oncol; 2015 Nov; 47(5):1759-66. PubMed ID: 26397063 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA‑3666 suppresses the growth and migration of glioblastoma cells by targeting KDM2A. Shou T; Yang H; Lv J; Liu D; Sun X Mol Med Rep; 2019 Feb; 19(2):1049-1055. PubMed ID: 30483744 [TBL] [Abstract][Full Text] [Related]
15. Circular RNA circFOXO3 regulates KDM2A by targeting miR-214 to promote tumor growth and metastasis in oral squamous cell carcinoma. Ai Y; Wu S; Zou C; Wei H J Cell Mol Med; 2022 Mar; 26(6):1842-1852. PubMed ID: 34117688 [TBL] [Abstract][Full Text] [Related]
16. LncRNA LINC01278 accelerates colorectal cancer progression via miR-134-5p/KDM2A axis. Xi C; Ye NY; Wang YB Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10526-10534. PubMed ID: 33155208 [TBL] [Abstract][Full Text] [Related]
17. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3. Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046 [TBL] [Abstract][Full Text] [Related]
18. Expression pattern and regulatory effect of lysine-specific demethylase 2A gene in clear cell renal cell carcinoma. Wang J; Li T; Li X; Zhang Y; Wang X BMC Urol; 2021 Aug; 21(1):108. PubMed ID: 34391411 [TBL] [Abstract][Full Text] [Related]
19. Histone demethylase KDM2A suppresses EGF-TSPAN8 pathway to inhibit breast cancer cell migration and invasion in vitro. Zhang H; Tu Y; Huang B; Xiao J; Xiao J; Wang J; Pei Y; Yang R; Feng J; Li J; Zhang X Biochem Biophys Res Commun; 2022 Nov; 628():104-109. PubMed ID: 36084547 [TBL] [Abstract][Full Text] [Related]
20. Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer. Liu H; Liu L; Holowatyj A; Jiang Y; Yang ZQ Mol Carcinog; 2016 May; 55(5):977-90. PubMed ID: 26207617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]